This fundamental study identifies the kinase DYRK1A as a novel component of the tuberous sclerosis complex (TSC) protein complex, which is central to cellular growth and cell size. The findings ...

The event will raise funds to further tuberous sclerosis complex (TSC) research and expand support programs for individuals and families affected by the disease. Formed in 1974 by four mothers ...

Cheating in examinations has evolved into a complex syndicate that involves principals of schools who are the centre ... It ...

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will attend the 2024 Child Neurology Society (CNS) ...

This study aims to describe a physical interaction between the kinase DYRK1A and the Tuberous Sclerosis Complex proteins (TSC1, TSC2, TBC1D7). Furthermore, this study aims to demonstrate that DYRK1A, ...

Marinus Pharmaceuticals has reported that the Phase III TrustTSC trial of oral ganaxolone in treating seizures linked to ...

The Grow Your Own Teacher Grant is allocating around half a million to both schools this year to address statewide teacher ...

The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, ...

(NASDAQ:MRNS) stock plunged after the company revealed disappointing data from the Phase 3 TrustTSC trial of oral ganaxolone for seizures associated with tuberous sclerosis complex (TSC ...

Last month, a second phase 3 blow for Marinus Pharmaceuticals prompted the Pennsylvania-based drugmaker to turn an eye toward ...

The CNIPA invalidated the Patent on the ground that the claims lack inventiveness over the combination of Evidence 6, ...